Building Bridges — The FBI, Academia, Industry and the Challenges of Synbio
August 14, 2009
Foley Partner and chair of the Health Care Industry Team Mark Waxman authored an article titled “Building Bridges—The FBI, Academia, Industry and the Challenges of Synbio” in the August 14, 2009 issue of BNA’s Life Sciences Law & Industry Report.
Reproduced with permission from Life Sciences Law & Industry Report, 3 LSLR 849 (Aug. 14, 2009). Copyright 2009 by The Bureau of National Affairs, Inc. (800-372-1033) http://www.bna.com.
Related Insights
July 15, 2025
Innovative Technology Insights
Navigating FDA’s Proposed Guidance on AI and Non-Animal Models: Safeguarding Innovation in Drug Development
In April 2025, the U.S. Food and Drug Administration (FDA) released a landmark guidance titled “Roadmap to Reducing Animal Testing in…
July 15, 2025
Health Care Law Today
Navigating FDA’s Proposed Guidance on AI and Non-Animal Models: Safeguarding Innovation in Drug Development
In April 2025, the U.S. Food and Drug Administration (FDA) released a landmark guidance titled “Roadmap to Reducing Animal Testing in…
July 15, 2025
Health Care Law Today
Colorado Medicaid: RAC Program Overhauled with Enhanced Transparency, Greater Provider Protections, and Increased Oversight
In June 2025, Colorado passed a new law that makes significant changes to the state’s Medicaid Recovery Audit Contractor (RAC) program….